Period of time： 2014年6期
Publisher： Informa Healthcare
Founded in： 2002
Total resources： 54
ISSN： 1474-0338
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 3,issue 6
Menu
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
By Aithal Guruprasad P in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.
Access to resources
Recommend
The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis
By Bensimon Gilbert,Doble Adam in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.Chemotherapy-induced peripheral neurotoxicity
By Cavaletti Guido,Marmiroli Paola in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.Rosuvastatin safety: lessons from the FDA review and post-approval surveillance
By Davidson Michael H in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.A benefit–risk assessment of class III antiarrhythmic agents
By Elming Hanne,Brendorp Bente,Pehrson Steen,Pedersen Ole Dyg,Køber Lars,Torp-Petersen Christian in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.Mucocutaneous side effects of antineoplastic chemotherapy
By Guillot B,Bessis D,Dereure O in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.Arsenic trioxide in the treatment of haematological malignancies
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.Risks of testosterone replacement therapy in ageing men
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.Disturbance of vision by COX-2 inhibitors
By Coulter David M,Clark David WJ in (2004)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa)
Expert Opinion on Drug Safety,volume 3,issue 6 , Vol. 3, Iss. 6, 2004-11 , pp.
Previous
Next